Abstract:Over the past several years, numerous studies investigated the anti-inflammatory effects of statin on patients with RA. However, the findings of the individual studies were often inconsistent or conflicting.The Pubmed, Web of Science, Embase, Cochrane Library and CNKI literature databases were searched in order to identify randomized controlled clinical trials where the association between the anti-inflammatory effect of statin and RA was investigated. Two researchers performed data extraction from eligible independently. Quality parameters and risk of bias in the included studies were assessed according to Cochrane's guidelines. The pooled Standardized Mean Difference (SMD) with a 95%CI was used to assess the anti-inflammatory effect of statin in patients with RA.Fifteen randomized controlled clinical, classified as "high quality" and with a relatively low risk of selection bias, were included in the meta-analysis. Of these, eight reported that there was no difference in the level of serum total lipids between the atorvastatin-treated and the conventional treatment group. However, the pooled analysis showed that atorvastatin could increase the level of serum amount of high-density lipoprotein (HDL) in RA patients by approximately x ± SD95% [HDL: SMD = 0.807, 95%CI = (0.187, 1.426), p = .011]. Meanwhile atorvastatin could reduce the level of serum low-density lipoprotein (LDL), total cholesterol (TC), and triglyceride (TG) in RA patient by x ± SD95% [LDL: SMD = -4.015, 95%CI = (-5.848, -2.183), p = .000; TC: SMD = -4.497, 95%CI = (-6.457, -2.537), p = .000; TG: SMD = -1.475, 95%CI = (-2.352, -0.599), p = .001]. Nine studies reported a change in C-Reactive Protein (CRP) after atorvastatin treatment, and the pooled analysis showed that atorvastatin decreased CRP in RA patients by x ± SD95% [SMD = -3.033, 95%CI = (-4.460, -1.606), p = .000]. Seven studies investigated the change of Erythrocyte Sedimentation Rate (ESR), and the pooled analysis showed that atorvastatin decreased ESR by x ± SD95% [SMD = -2.097, 95%CI = (-3.408, -0.786), p = .002]. Nine studies reported the improvement of disease activity score in RA patients after taking atorvastatin for 12 weeks, and the pooled analysis showed atorvastatin could decrease the DAS28 score in RA patients by x ± SD95% [SMD = -2.001, 95%CI = (-3.191, -0.811), p = .001].Statins have a significant anti-inflammatory effect in RA patients. However, atorvastatin was superior to simvastatin both in terms of its anti-inflammatory and lipid-lowering activities.

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

The effect of simvastatin on the serum monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 levels in diabetic rats

Impact of Simvastatin on Adipose Tissue: Pleiotropic Effects in Vivo

The Effects of Simvastatin Therapy on Endothelial Function and Inflammatory Factor in Type 2 Diabetes Mellitus Without Cardiovascular Disease

Effect of simvastatin on the level of monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 in diabetic rats

Anti-myocardial Ischemic Effects of Simvastatin on Patients with Stable Angina Pectoris and Average Lipid Levels

Simvastatin inhibits ox-LDL-induced inflammatory adipokines secretion via amelioration of ER stress in 3T3-L1 adipocyte.

The relationship of serum inflammatory factors, adiponectin and early atherosclerotic in type 2 diabetes

Relationship of acute-phase serum amyloid A and high-density lipoprotein cholesterol with atherosclerosis in type 2 diabetes

Simvastatin Attenuates the Additive Effects of TNF-α and IL-18 on the Connexin 43 Up-Regulation and Over-Proliferation of Cultured Aortic Smooth Muscle Cells.

Effects of statins on coronary atherosclerotic plaque in patients with coronary heart disease and type 2 diabetes with mild elevated LDL-C

Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome

The Relationship Between Serum Levels of Inflammatory Factors,Adiponectin and Atherosclerosis in the Patients with Type 2 Diabetes Mellitus

The Inhibitory Effect of Simvastatin on the ADMA-induced Inflammatory Reaction is Mediated by MAPK Pathways in Endothelial Cells.

Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control

The effect of hydrophilic statins on adiponectin, leptin, visfatin, and vaspin levels in streptozocin-induced diabetic rats

Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice

Effect of Simvastatin on Serum Level of Inflammatory Factors in Acute Coronary Syndrome

Effect of Atorvastatin Versus Rosuvastatin on Levels of Serum Lipids, Inflammatory Markers and Adiponectin in Patients with Hypercholesterolemia

The Anti-Inflammatory Effects of Statins on Patients with Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of 15 Randomized Controlled Trials